Faculty Disclosures

Article Outline

 

The authors who contributed to this publication have disclosed the following industry relationships:

Mark J. Alberts, MD, is a member of the Speaker's Bureau and serves as a consultant for diaDexus, Inc.

Jeffrey L. Anderson, MD, has received speaker honoraria from diaDexus, Inc. which has also supported research projects with his institution.

Marshall A. Corson, MD, is on the speaker's bureau for Abbott Laboratories, diaDexus, Inc., Forest Pharmaceuticals, Merck/Schering-Plough, Novartis, Oscient, and Pfizer, Inc,; his wife is an employee of diaDexus, Inc., and is a shareholder in Merck and Novartis.

Michael H. Davidson, MD, is a member of the Speakers' Bureau for Abbott Laboratories, AstraZeneca Pharmaceuticals, Daiichi-Sankyo, Inc., diaDexus, Inc., Merck & Co., Inc., Merck/Schering-Plough, Oscient Pharmaceuticals, Pfizer, Inc., and Takeda Pharmaceuticals; serves as a consultant for Abbott Laboratories, AstraZeneca Pharmaceuticals, Daiichi-Sankyo, Inc., diaDexus, Inc., Merck & Co., Inc., Merck/Schering-Plough, Pfizer, Inc., Roche Pharmaceuticals, sanofi aventis, and Takeda Pharmaceuticals; has received grant/research support from Abbott Laboratories, AstraZeneca Pharmaceuticals, Daiichi-Sankyo, Inc., Merck & Co., Inc., Merck/Schering-Plough, Pfizer, Inc., Roche Pharmaceuticals, and Takeda Pharmaceuticals; is on the advisory board for Abbott Laboratories, Access Health, Atherogenics, AstraZeneca Pharmaceuticals, Daiichi-Sankyo, Inc., Merck & Co., Inc., Merck/Schering-Plough, Oscient Pharmaceuticals, Pfizer, Inc., Roche Pharmaceuticals, and Takeda Pharmaceuticals; is on the Board of Directors for Angiogen and Sonogene and is Chief Medical Officer of Professional Evaluation, Inc.

Philip B. Gorelick, MD, serves as a consultant for Bayer; is on the Speaker's Bureau and a Stroke Steering Committee Member for Boehringer Ingelheim; and is a study adjudicator for Pfizer, Inc.

Peter H. Jones, MD, has received research grants from Abbott Laboratories, AstraZeneca; and serves as a consultant for Abbott Laboratories, AstraZeneca, Pfizer, Inc, and Merck/Schering-Plough.

Amir Lerman, MD, has no financial arrangement or affiliation with a corporate organization or manufacturer of a product discussed in this supplement.

Joseph P. McConnell, PhD, has no financial arrangement or affiliation with a corporate organization or manufacturer of a product discussed in this supplement.

Howard S. Weintraub, MD, is a member of the Speaker's Bureau for Pfizer, Inc, CVT, diaDexus, Inc., Novartis, Merck & Co., and Takeda Pharmaceuticals.